Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail)

v3.23.1
Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 7,231,112 188,711
Employee Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 79,661 52,148
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially antidilutive securities outstanding excluded from the computation of diluted weighted average shares 7,151,451 136,563